- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06363045
Comparative Study of the NIDEK TONOREF III with Predicate Devices
March 6, 2025 updated by: Nidek Co. LTD.
Comparative Study of the NIDEK TONOREF III with the Haag-Streit, Perkins Hand-held Applanation Tonometer for Tonometry Function and NIDEK TONOREF III with the NIDEK CEM-530 for Pachymetry Function
The primary objective of this clinical study is to prove that tonometry values for NIDEK TONOREF III are comparable to the predicate device and to prove that the pachymeter function of NIDEK TONOREF III is equivalent to the predicate device.
The secondary objective is to demonstrate that the test device is as safe as the predicate devices.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
183
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Birmingham, United Kingdom, B4 7ET, UK
- Aston University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Exclusion criteria
- Subjects with only one functional eye;
- Those with one eye having poor or eccentric fixation;
- Those with corneal scarring or who have had corneal surgery including corneal laser surgery;
- Microphthalmos;
- Buphthalmos;
- Contact lens wearers;
- Dry eyes;
- Lid squeezers - blepharospasm;
- Nystagmus;
- Keratoconus;
- Any other corneal or conjunctival pathology or infection.
- central corneal thickness greater than 0,600 mm or less than 0,500 mm (2 standard deviations about the human mean)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adults 18 years old or older
NIDEK TONOREFIII
|
Nidek CEM-530 is a non-contact ophthalmic microscope, optical pachymeter, and camera used for examination of the corneal endothelium and for measurement of the thickness of the cornea.
The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye.
Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Equivalent to legally-marketed devices
Time Frame: One or two study visits per subject. One visit is less than two hours.
|
Agreement of intraocular pressure (mmHg) measurement for TONOREFIII and PAT
|
One or two study visits per subject. One visit is less than two hours.
|
|
Equivalent to the pachymeter function
Time Frame: One or two study visits per subject. One visit is less than two hours.
|
Agreement of central corneal thickness (µm) measurement for TONOREF III and CEM-530
|
One or two study visits per subject. One visit is less than two hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The numbers of adverse events
Time Frame: One or two study visits per subject. One visit is less than two hours.
|
To demonstrate that the test device is as safe as the predicate devices.
|
One or two study visits per subject. One visit is less than two hours.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Tadakazu Ichimura, Nidek Co. LTD.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 27, 2024
Primary Completion (Actual)
December 13, 2024
Study Completion (Actual)
December 13, 2024
Study Registration Dates
First Submitted
March 24, 2024
First Submitted That Met QC Criteria
April 9, 2024
First Posted (Actual)
April 12, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 6, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- NIDEK-TONOREF-UK-0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraocular Pressure
-
Icare Finland OyCompleted
-
Vanderbilt University Medical CenterEnrolling by invitation
-
Inonu UniversityCompletedIntraocular PressureTurkey
-
Medical University of ViennaCompletedIntraocular PressureAustria
-
Bausch & Lomb IncorporatedCompletedIntraocular PressureUnited States
-
Inonu UniversityCompletedIntraocular Pressure
-
The University of Texas Health Science Center,...Robert Cizik Eye ClinicCompletedIntraocular PressureUnited States
-
Isfahan University of Medical SciencesCompletedIntraocular PressureIran, Islamic Republic of
-
Tel-Aviv Sourasky Medical CenterUnknownIntraocular PressureIsrael
-
Marmara UniversityTerminatedIntraocular Pressure | Intracranial Pressure | Positive End-expiratory PressureTurkey
Clinical Trials on NIDEK CEM-530
-
Nidek Co. LTD.Completed
-
Nidek Co. LTD.CompletedCorneal Endothelial Cell LossUnited States
-
Graziella di GreziaLink Campus University; University of Campania Luigi VanvitelliEnrolling by invitationBreast Cancer Diagnosis | Breast Cancer PreventionItaly
-
Doheny Image Reading CenterCompletedAge-related Macular Degeneration (AMD)United States
-
Shanghai 10th People's HospitalCompletedMyocardial Infarction | Atrial FibrillationChina
-
Nidek Co. LTD.CompletedIntraocular Pressure
-
Graziella di GreziaLink Campus University; University of Campania Luigi VanvitelliEnrolling by invitationBreast Cancer Diagnosis | Breast Cancer DetectionItaly
-
ReVivo Medical, Corp.The Cleveland Clinic; Albany Medical College; IGEARecruitingNeck Pain | Spondylosis | Spondylosis With Myelopathy | Spondylosis With Radiculopathy | Spondylosis With Radiculopathy Cervical Region | Intervertebral Disc Disorder CervicalUnited States
-
AbbVieCompletedHepatic ImpairmentUnited States, New Zealand